These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27753537)

  • 1. Distribution and Penetration of Intracerebroventricularly Administered 2'OMePS Oligonucleotide in the Mouse Brain.
    Casaca-Carreira J; Temel Y; Larrakoetxea I; Jahanshahi A
    Nucleic Acid Ther; 2017 Feb; 27(1):4-10. PubMed ID: 27753537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.
    Monine M; Norris D; Wang Y; Nestorov I
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):639-654. PubMed ID: 33991294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trafficking of intracerebroventricularly injected antisense oligonucleotides in the mouse brain.
    Chauhan NB
    Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):353-7. PubMed ID: 12477284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular Administration of a 2'-O-Methyl Phosphorothioate Antisense Oligonucleotide Results in Activation of the Innate Immune System in Mouse Brain.
    Toonen LJA; Casaca-Carreira J; Pellisé-Tintoré M; Mei H; Temel Y; Jahanshahi A; van Roon-Mom WMC
    Nucleic Acid Ther; 2018 Apr; 28(2):63-73. PubMed ID: 29565739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-cell map of antisense oligonucleotide activity in the brain.
    Mortberg MA; Gentile JE; Nadaf NM; Vanderburg C; Simmons S; Dubinsky D; Slamin A; Maldonado S; Petersen CL; Jones N; Kordasiewicz HB; Zhao HT; Vallabh SM; Minikel EV
    Nucleic Acids Res; 2023 Aug; 51(14):7109-7124. PubMed ID: 37188501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of Radioactively Labeled Splice Modulating Antisense Oligonucleotides After Intracerebroventricular and Intrathecal Injection in Mice.
    Metz T; Welling MM; Suidgeest E; Nieuwenhuize E; de Vlaam T; Curtis D; Hailu TT; van der Weerd L; van Roon-Mom WMC
    Nucleic Acid Ther; 2024 Feb; 34(1):26-34. PubMed ID: 38386285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein.
    Banks WA; Farr SA; Butt W; Kumar VB; Franko MW; Morley JE
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1113-21. PubMed ID: 11356936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotides in therapy for neurodegenerative disorders.
    Evers MM; Toonen LJ; van Roon-Mom WM
    Adv Drug Deliv Rev; 2015 Jun; 87():90-103. PubMed ID: 25797014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System.
    Mendonça MCP; Kont A; Aburto MR; Cryan JF; O'Driscoll CM
    Mol Pharm; 2021 Apr; 18(4):1491-1506. PubMed ID: 33734715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections.
    Metz T; Kuijper EC; van Roon-Mom WMC
    Methods Mol Biol; 2022; 2434():333-341. PubMed ID: 35213029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion.
    Broaddus WC; Prabhu SS; Gillies GT; Neal J; Conrad WS; Chen ZJ; Fillmore H; Young HF
    J Neurosurg; 1998 Apr; 88(4):734-42. PubMed ID: 9525721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system.
    Zeniya S; Kuwahara H; Daizo K; Watari A; Kondoh M; Yoshida-Tanaka K; Kaburagi H; Asada K; Nagata T; Nagahama M; Yagi K; Yokota T
    J Control Release; 2018 Aug; 283():126-134. PubMed ID: 29753959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.
    Vuillemenot BR; Korte S; Wright TL; Adams EL; Boyd RB; Butt MT
    Toxicol Sci; 2016 Jul; 152(1):3-9. PubMed ID: 27354708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical and practical applications of the intracerebroventricular route for CSF sampling and drug administration in CNS drug discovery research: a mini review.
    Kuo A; Smith MT
    J Neurosci Methods; 2014 Aug; 233():166-71. PubMed ID: 24937765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNS.
    Wahlestedt C; Khorkova O
    Cell Mol Neurobiol; 2021 Jul; 41(5):849-853. PubMed ID: 32656646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?
    Casaca-Carreira J; Temel Y; Hescham SA; Jahanshahi A
    Mol Neurobiol; 2018 Apr; 55(4):2780-2788. PubMed ID: 28455692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration.
    Jafar-Nejad P; Powers B; Soriano A; Zhao H; Norris DA; Matson J; DeBrosse-Serra B; Watson J; Narayanan P; Chun SJ; Mazur C; Kordasiewicz H; Swayze EE; Rigo F
    Nucleic Acids Res; 2021 Jan; 49(2):657-673. PubMed ID: 33367834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide-based therapy for neurodegenerative diseases.
    Magen I; Hornstein E
    Brain Res; 2014 Oct; 1584():116-28. PubMed ID: 24727531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantageous toxicity profile of inhaled antisense oligonucleotides following chronic dosing in non-human primates.
    Guimond A; Viau E; Aubé P; Renzi PM; Paquet L; Ferrari N
    Pulm Pharmacol Ther; 2008 Dec; 21(6):845-54. PubMed ID: 18761414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient in vivo delivery of antisense oligonucleotide to choroid plexus.
    Piao W; Nishina K; Yoshida-Tanaka K; Kuwahara H; Nishina T; Sakata M; Mizusawa H; Yokota T
    J Med Dent Sci; 2013 Mar; 60(1):9-16. PubMed ID: 23917958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.